Centessa Pharmaceuticals plc (CNTA) Financials
CNTA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 377.4 million | 118.0 million |
2023-06-30 | 392.9 million | 116.3 million |
2023-03-31 | 403.9 million | 110.6 million |
2022-12-31 | 444.3 million | 108.1 million |
CNTA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -37.4 million | 7.6 million |
2023-06-30 | -44.1 million | 7.2 million |
2023-03-31 | -47.9 million | 7.2 million |
2022-12-31 | -52.2 million | 6.6 million |
CNTA Net Income
No data available :(
CNTA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 281.3 million | - | 9.5 million |
2023-06-30 | 303.6 million | - | 9.6 million |
2023-03-31 | 346.2 million | - | 9.7 million |
2022-12-31 | 393.6 million | - | - |
CNTA Shares Outstanding
CNTA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 43000 | 28.2 million | 12.0 million | - |
2023-06-30 | 10000 | 33.7 million | 13.3 million | - |
2023-03-31 | 88000 | 32.8 million | 16.1 million | - |
2022-12-31 | 652000 | 27.8 million | 13.8 million | - |
CNTA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 236618 |
2023-06-30 | - | 237762 |
2023-03-31 | - | 89807 |
2022-12-31 | - | 36269 |
CNTA
Price: $9.67
52 week price:
Earnings Per Share: -1.57 USD
P/E Ratio: -6.56
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 66900
Market Capitalization: 1.1 billion